Indeed, while specific MYCN inhibition by anti-MYCN BGA002 can be proposed as a single treatment for MNA NB patients, our results also show that its activity can restore the responsiveness of the immune system against NB, opening the way to use anti-MYCN inhibition in combination with immune-therapy. This evidence concerns the gene MYCN and neuroblastoma.